Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Colonic Diseases, Functional

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Colonic Diseases, Functional in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benveniste, J; Bossant, MJ; Chaussade, S; Cherouki, N; Colombel, JF; Couturier, D; Denizot, Y; Nathan, N1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Colonic Diseases, Functional

ArticleYear
PAF-acether and acetylhydrolase in stool of patients with Crohn's disease.
    Digestive diseases and sciences, 1992, Volume: 37, Issue:3

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Chromatography, High Pressure Liquid; Colonic Diseases, Functional; Crohn Disease; Diarrhea; Feces; Female; Humans; Malabsorption Syndromes; Male; Middle Aged; Phospholipases A; Platelet Activating Factor

1992